|
Market Closed -
Nasdaq
16:00:00 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 112.89 USD | -0.89% |
|
+1.29% | +67.74% |
| 09-18 | Halozyme Prices $1.3 Billion Convertible Senior Notes Offering | MT |
| 09-17 | Halozyme Therapeutics, Inc. to Seek Acquisitions | CI |
| Market Cap | 12.81B 11.27B 10.66B 9.67B 18.15B 1,230B 18.26B 128B 49.28B 628B 48.1B 47.06B 2,017B | P/E 2026 * |
15.7x | P/E 2027 * | 12.6x |
|---|---|---|---|---|---|
| Enterprise Value | 14.16B 12.45B 11.77B 10.68B 20.06B 1,359B 20.17B 141B 54.44B 693B 53.15B 52B 2,228B | EV / Sales 2026 * |
7.64x | EV / Sales 2027 * | 6.41x |
| Free-Float |
98.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| HALO | Delayed | |
CBOE
| HALO | Real-time | |
|
Tradegate
| RV7 | Real-time | |
|
Boerse Muenchen
| RV7 | Real-time | |
|
Xetra
| RV7 | Delayed | |
|
Mexican S.E.
| HALO * | End-of-day quote | |
|
Deutsche Boerse AG
| RV7 | Delayed | |
|
Borsa Italiana
| 1HALO | End-of-day quote | |
|
Börse Stuttgart
| RV7 | Delayed | |
|
Berne S.E.
| RV7 | End-of-day quote |
Last Transcript: Halozyme Therapeutics, Inc.
| 1 day | -0.89% | ||
| 1 week | +1.29% | ||
| Current month | +6.01% | ||
| 1 month | +7.16% | ||
| 3 months | +50.60% | ||
| 6 months | +83.17% | ||
| Current year | +67.74% |
| 1 week | 111.07 |  | 116.84 |
| 1 month | 103.47 | | 116.84 |
| Current year | 61.32 | | 116.84 |
| 1 year | 61.22 | | 116.84 |
| 3 years | 32.83 | | 116.84 |
| 5 years | 29.85 | | 116.84 |
| 10 years | 8.18 | | 116.84 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 2014-01-05 |
David Ramsay
DFI | Director of Finance/CFO | 61 | 2013-04-30 |
| Director of Finance/CFO | - | 2026-06-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 2013-03-27 |
Helen Torley
BRD | Director/Board Member | 63 | 2014-01-05 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/16/26 | Sell | Director | -18,996 | 0.0167% | ||
| 9/11/26 | Exercice | Chief Executive Officer | 60,000 | 0.0529% | ||
| 9/1/26 | Free | Director | 2,939 | 0.0026% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.89% | +1.29% | +53.07% | +188.35% | 12.93B | |
| -0.06% | -0.54% | +89.27% | +42.56% | 367B | |
| +2.56% | +4.41% | +29.88% | -11.16% | 66.89B | |
| 0.00% | -0.71% | -1.58% | -13.77% | 7.54B | |
| +0.40% | -1.80% | -24.93% | -11.60% | 4.38B | |
| +0.81% | -1.19% | -34.87% | +3.48% | 4.07B | |
| -1.08% | -3.44% | -29.63% | -16.71% | 3.02B | |
| +4.55% | +4.25% | -5.17% | +58.83% | 2.48B | |
| -0.84% | -4.15% | -21.36% | -32.38% | 1.91B | |
| -4.14% | -0.63% | +18.85% | +89.42% | 1.85B | |
| Average | +0.25% | +0.56% | +7.35% | +29.70% | 47.21B | |
| Weighted average by Cap. | +1.23% | +1.65% | +74.30% | +36.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.85B 1.63B 1.54B 1.4B 2.63B 178B 2.64B 18.46B 7.13B 90.79B 6.96B 6.81B 292B | 2.05B 1.8B 1.71B 1.55B 2.9B 197B 2.92B 20.42B 7.89B 100B 7.7B 7.53B 323B |
| Net income | 869M 764M 723M 655M 1.23B 83.39B 1.24B 8.65B 3.34B 42.55B 3.26B 3.19B 137B | 1.07B 939M 888M 806M 1.51B 103B 1.52B 10.63B 4.11B 52.31B 4.01B 3.92B 168B |
| Net Debt | 1.34B 1.18B 1.12B 1.01B 1.9B 129B 1.91B 13.38B 5.17B 65.83B 5.05B 4.94B 212B | 320M 281M 266M 241M 453M 30.67B 455M 3.18B 1.23B 15.65B 1.2B 1.17B 50.29B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | US$112.89 | -0.89% | 2,236,726 |
| 26-09-25 | US$113.90 | -1.15% | 1,958,390 |
| 26-09-24 | US$115.22 | +2.47% | 3,172,136 |
| 26-09-23 | US$112.44 | -2.34% | 2,702,793 |
| 26-09-22 | US$115.13 | +3.30% | 4,151,542 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
